Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial.
Saved in:
| Title: | Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial. |
|---|---|
| Authors: | Jayaram A; University College London Cancer Institute, London, UK., Wingate A; University College London Cancer Institute, London, UK., Wetterskog D; University College London Cancer Institute, London, UK., Wheeler G; University College London Cancer Institute, London, UK., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York, USA., Jones R; University of Glasgow, The Beatson West of Scotland Cancer Centre, Glasgow, UK., Berruti A; University of Brescia, Spedali Civili Hospital, Brescia, Italy., Lefresne F; Janssen-Cilag, France., Lahaye M; Janssen-Cilag, France., Thomas S; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA., Gormley M; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA., Meacham F; Resolution BioScience, Inc., Kirkland, USA., Garg K; Resolution BioScience, Inc., Kirkland, USA., Lim LP; Resolution BioScience, Inc., Kirkland, USA., Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Tombal B; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium., Ricci D; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA., Attard G; University College London Cancer Institute, London, UK. Electronic address: g.attard@ucl.ac.uk. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Jun; Vol. 32 (6), pp. 726-735. Date of Electronic Publication: 2021 Mar 29. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33794293 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jayaram+A%22">Jayaram A</searchLink>; University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Wingate+A%22">Wingate A</searchLink>; University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Wetterskog+D%22">Wetterskog D</searchLink>; University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Wheeler+G%22">Wheeler G</searchLink>; University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Sternberg+CN%22">Sternberg CN</searchLink>; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York, USA.<br /><searchLink fieldCode="AU" term="%22Jones+R%22">Jones R</searchLink>; University of Glasgow, The Beatson West of Scotland Cancer Centre, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Berruti+A%22">Berruti A</searchLink>; University of Brescia, Spedali Civili Hospital, Brescia, Italy.<br /><searchLink fieldCode="AU" term="%22Lefresne+F%22">Lefresne F</searchLink>; Janssen-Cilag, France.<br /><searchLink fieldCode="AU" term="%22Lahaye+M%22">Lahaye M</searchLink>; Janssen-Cilag, France.<br /><searchLink fieldCode="AU" term="%22Thomas+S%22">Thomas S</searchLink>; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Gormley+M%22">Gormley M</searchLink>; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Meacham+F%22">Meacham F</searchLink>; Resolution BioScience, Inc., Kirkland, USA.<br /><searchLink fieldCode="AU" term="%22Garg+K%22">Garg K</searchLink>; Resolution BioScience, Inc., Kirkland, USA.<br /><searchLink fieldCode="AU" term="%22Lim+LP%22">Lim LP</searchLink>; Resolution BioScience, Inc., Kirkland, USA.<br /><searchLink fieldCode="AU" term="%22Merseburger+AS%22">Merseburger AS</searchLink>; Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Tombal+B%22">Tombal B</searchLink>; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Ricci+D%22">Ricci D</searchLink>; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Attard+G%22">Attard G</searchLink>; University College London Cancer Institute, London, UK. Electronic address: g.attard@ucl.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2021 Jun; Vol. 32 (6), pp. 726-735. <i>Date of Electronic Publication: </i>2021 Mar 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33794293 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2021.03.196 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 726 Titles: – TitleFull: Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jayaram A – PersonEntity: Name: NameFull: Wingate A – PersonEntity: Name: NameFull: Wetterskog D – PersonEntity: Name: NameFull: Wheeler G – PersonEntity: Name: NameFull: Sternberg CN – PersonEntity: Name: NameFull: Jones R – PersonEntity: Name: NameFull: Berruti A – PersonEntity: Name: NameFull: Lefresne F – PersonEntity: Name: NameFull: Lahaye M – PersonEntity: Name: NameFull: Thomas S – PersonEntity: Name: NameFull: Gormley M – PersonEntity: Name: NameFull: Meacham F – PersonEntity: Name: NameFull: Garg K – PersonEntity: Name: NameFull: Lim LP – PersonEntity: Name: NameFull: Merseburger AS – PersonEntity: Name: NameFull: Tombal B – PersonEntity: Name: NameFull: Ricci D – PersonEntity: Name: NameFull: Attard G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2021 Jun Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1569-8041 Numbering: – Type: volume Value: 32 – Type: issue Value: 6 Titles: – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology Type: main |
| ResultId | 1 |